BioSight
Companies
LENZ Therapeutics, Inc. logo

LENZ

NASDAQSOLANA BEACH, CA
LENZ Therapeutics, Inc.

LENZ Therapeutics is a biotech company commercializing VIZZ, a therapeutic product that has received regulatory approval. VIZZ targets a defined patient population, and LENZ is planning its market entry strategy across select geographic regions. The company is at the commercial stage, focused on manufacturing scale-up, regulatory compliance, and bringing VIZZ to market while evaluating potential future product candidates.

Price history not yet available for LENZ.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar